As a result of our research, we have concluded that dCK might be a new therapeutic target for increasing the radiosensitivity of HeLa cells and that HSP90 inhibitors might help to increase the effectiveness of radiation therapy for cervical cancer. Here, HSP90AA1 is linked to cervical cancer.